Phase I/II clinical trial - Pédiatrie Tumeurs cérébrales

CheckMate-908 (CA209-908)
Pédiatrie Tumeurs cérébrales
Essai clinique fermé
Public cible
Phase Ib /II Clinical Trial of Nivolumab Monotherapy and Nivolumab in Combination with Ipilimumab in Pediatric Subjects with High Grade Primary CNS Malignancies.
Description de l'essai

The purpose of this study is to determine the safety and effectiveness of nivolumab alone and in combination with ipilimumab in pediatric patients with high grade primary central nervous system (CNS) malignancies.